Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Paclitaxel/Carboplatin Followed by Chemoradiotherapy for Advanced Head and Neck Cancer
NCT00004094Phase 2Unknown
- Sponsor
- National Cancer Institute
- Start
- Aug 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in head and neck squamous cell carcinoma (HNSCC), sponsored by National Cancer Institute. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00004094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004094.